Cardiff Oncology
CRDF
18 hedge funds and large institutions have $570K invested in Cardiff Oncology in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 4 closing their positions.
5% less funds holding
Funds holding: 19 → 18 (-1)
7.61% less ownership
Funds ownership: 13.17% → 5.55% (-7.6%)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
58% less capital invested
Capital invested by funds: $1.35M → $570K (-$780K)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$14.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$10K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$4.62K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$74 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LWA
LWS Wealth Advisors
Basking Ridge,
New Jersey
|
-$282K |
| 2 |
Renaissance Technologies
New York
|
-$251K |
| 3 |
AC
Armistice Capital
New York
|
-$103K |
| 4 |
Barclays
London,
United Kingdom
|
-$25K |
| 5 |
ECM
ETrade Capital Management
Arlington,
Virginia
|
-$14K |
CRDF Hedge Fund Activity: Q1 2020 in Review
18 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2020, worth a combined $570K — down 58% from $1.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CRDF and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 2 added.
The largest buyer was Northern Trust, opening a new position worth an estimated $14.3K. The largest seller was LWS Wealth Advisors, exiting entirely with an estimated $282K sold.
- 18 institutional investors held Cardiff Oncology (CRDF) as of Q1 2020, down from 19 in Q4 2019.
- Funds reported $570K of Cardiff Oncology stock for Q1 2020, down 58% quarter-over-quarter.
- 3 funds opened new Cardiff Oncology positions in Q1 2020 and 4 closed out, a net change of -1 holder.
- The largest Cardiff Oncology buyer in Q1 2020 was Northern Trust, an estimated $14.3K added.
- The largest Cardiff Oncology seller in Q1 2020 was LWS Wealth Advisors, an estimated $282K sold.
Based on aggregated 13F filings for Q1 2020.